Related Experiment Videos
Common variable immunodeficiency (CVID) and MxA-protein expression in blood leucocytes
J A Rump1, D Jakschiess, U Walker
1Abteilung Rheumatologie, Med. Univ. Klinik, Freiburg, Germany.
Clinical and Experimental Immunology
|July 1, 1995
Summary
This study investigated Common Variable Immunodeficiency (CVID) pathogenesis. MxA-protein levels in patients suggest neither chronic viral infections nor autoimmune diseases are the primary cause of CVID.
Area of Science:
- Immunology
- Virology
- Autoimmunity
Background:
- Common Variable Immunodeficiency (CVID) pathogenesis is unclear, with suspected links to chronic viral infections or autoimmune conditions.
- MxA-protein in leukocytes indicates interferon system activation, a marker for viral and autoimmune diseases.
- Formal proof for viral involvement in CVID is currently lacking.
Purpose of the Study:
- To investigate the immunopathogenic mechanism of CVID by assessing MxA-protein expression.
- To determine if chronic viral infection or autoimmune conditions contribute to CVID.
- To evaluate the host's interferon system activation in CVID patients.
Main Methods:
- Measured MxA-protein levels in leukocyte lysates from 15 patients with hypogammaglobulinaemia (13 CVID, 1 hyper-IgM, 1 B-CLL with HPV).
- Assessed MxA-protein expression in vivo and in vitro response to interferon-alpha (IFN-alpha).
- Correlated MxA expression with CD4/CD8 ratios and CD8/CD57+ T cell counts.
Main Results:
- Only one patient (B-CLL with HPV) showed strong MxA-protein expression; two CVID patients were borderline, and 12 were negative.
- No correlation was found between MxA expression and low CD4/CD8 ratios or increased CD8/CD57+ T cells.
- Peripheral blood leukocytes from MxA-negative CVID patients produced normal MxA-protein levels upon in vitro IFN-alpha stimulation.
Conclusions:
- The findings argue against a chronic viral or autoimmune pathogenesis for Common Variable Immunodeficiency (CVID).
- MxA-protein expression is not a reliable indicator of underlying viral or autoimmune processes in most CVID patients.
- Further research is needed to elucidate the specific immunopathogenic mechanisms of CVID.